← Stocks · TNXP record
Signal record & history · Trifecta Signals
Tonix has been flagged by the Trifecta screener 2 times since 2022. 2 signals confirmed; the median confirmed signal is down 73.6% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Aug 2022 · Latest Feb 2025 · Confirmed 2 of 2 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since August 2022, Tonix has had two Early signals, two confirmed. One of the two decided signals gained +10% within 90 days, and zero of two finished ahead of the S&P 500 since confirmation. One signal carried a caution flag.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for TNXP and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Tonix Pharmaceuticals Holding is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. Its market value of about $89 million places it in the small-cap group.
Tonix Pharmaceuticals Holding’s standout Trifecta run followed a February 2025 confirmation, gaining about 435% over the next 90 days. For classification, it sat in the small-cap group when that signal fired.
At the most recent close, Wednesday, November 4, the shares finished at $5.11, down 1.5% on the day. Over the past week, the shares have traded in a narrow range between about $5.10 and $5.28.
